• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药剂师进行出院指导的成本效益评估。

A cost-effectiveness evaluation of hospital discharge counseling by pharmacists.

作者信息

Chinthammit Chanadda, Armstrong Edward P, Warholak Terri L

机构信息

Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, AZ 85721, USA.

出版信息

J Pharm Pract. 2012 Apr;25(2):201-8. doi: 10.1177/0897190011418512. Epub 2011 Oct 10.

DOI:10.1177/0897190011418512
PMID:21987529
Abstract

OBJECTIVES

This study estimated the cost-effectiveness of pharmacist discharge counseling on medication-related morbidity in both the high-risk elderly and general US population.

METHODS

A cost-effectiveness decision analytic model was developed using a health care system perspective based on published clinical trials. Costs included direct medical costs, and the effectiveness unit was patients discharged without suffering a subsequent adverse drug event. A systematic review of published studies was conducted to estimate variable probabilities in the cost-effectiveness model. To test the robustness of the results, a second-order probabilistic sensitivity analysis (Monte Carlo simulation) was used to run 10 000 cases through the model sampling across all distributions simultaneously.

RESULTS

Pharmacist counseling at hospital discharge provided a small, but statistically significant, clinical improvement at a similar overall cost. Pharmacist counseling was cost saving in approximately 48% of scenarios and in the remaining scenarios had a low willingness-to-pay threshold for all scenarios being cost-effective. In addition, discharge counseling was more cost-effective in the high-risk elderly population compared to the general population.

CONCLUSION

This cost-effectiveness analysis suggests that discharge counseling by pharmacists is quite cost-effective and estimated to be cost saving in over 48% of cases. High-risk elderly patients appear to especially benefit from these pharmacist services.

摘要

目的

本研究评估了药剂师出院辅导对美国高危老年人和普通人群药物相关发病率的成本效益。

方法

基于已发表的临床试验,从医疗保健系统的角度开发了一个成本效益决策分析模型。成本包括直接医疗成本,有效性指标是出院后未发生后续药物不良事件的患者。对已发表的研究进行系统综述,以估计成本效益模型中的可变概率。为检验结果的稳健性,使用二阶概率敏感性分析(蒙特卡罗模拟)在模型中同时对所有分布进行抽样,运行10000个案例。

结果

出院时药剂师辅导带来了微小但具有统计学意义的临床改善,总体成本相近。在约48%的情况下,药剂师辅导可节省成本,在其余情况下,所有情况的成本效益支付意愿阈值都较低。此外,与普通人群相比,出院辅导在高危老年人群中更具成本效益。

结论

这项成本效益分析表明,药剂师进行出院辅导具有很高的成本效益,估计在超过48%的案例中可节省成本。高危老年患者似乎尤其受益于这些药剂师服务。

相似文献

1
A cost-effectiveness evaluation of hospital discharge counseling by pharmacists.药剂师进行出院指导的成本效益评估。
J Pharm Pract. 2012 Apr;25(2):201-8. doi: 10.1177/0897190011418512. Epub 2011 Oct 10.
2
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
3
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
4
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
5
The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.卡莫司汀植入剂与替莫唑胺治疗新诊断的高级别胶质瘤的有效性和成本效益:一项系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. doi: 10.3310/hta11450.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
7
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.巴雷特食管的监测:通过系统评价、专家研讨会和经济模型探索不确定性
Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080.
8
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.拓扑替康、聚乙二醇化脂质体盐酸多柔比星和紫杉醇用于晚期卵巢癌二线或后续治疗:一项系统评价和经济学评估
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. doi: 10.3310/hta10090.
9
Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation.口服纳曲酮用于预防曾对阿片类药物依赖的吸毒者复吸:一项系统评价与经济学评估
Health Technol Assess. 2007 Feb;11(6):iii-iv, 1-85. doi: 10.3310/hta11060.
10
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.

引用本文的文献

1
Financial impact of medication reviews by clinical pharmacists to reduce in-hospital adverse drug events: a return-on-investment analysis.临床药师进行药物审查以减少院内药物不良事件的财务影响:投资回报分析。
Int J Clin Pharm. 2024 Apr;46(2):496-505. doi: 10.1007/s11096-023-01683-w. Epub 2024 Feb 5.
2
Developing and piloting a cross-sectoral hospital pharmacist intervention for patients in transition between hospital and general practice.为处于医院与全科医疗交接阶段的患者开发并试行跨部门医院药剂师干预措施。
Ther Adv Drug Saf. 2023 Mar 18;14:20420986231159221. doi: 10.1177/20420986231159221. eCollection 2023.
3
The medication discrepancy detection service: A cost-effective multidisciplinary clinical approach.
用药差异检测服务:一种具有成本效益的多学科临床方法。
Aten Primaria. 2021 Jan;53(1):43-50. doi: 10.1016/j.aprim.2020.04.008. Epub 2020 Sep 29.
4
Role of the pharmacist in reducing healthcare costs: current insights.药剂师在降低医疗成本中的作用:当前见解
Integr Pharm Res Pract. 2017 Jan 25;6:37-46. doi: 10.2147/IPRP.S108047. eCollection 2017.
5
Cost-effectiveness of a transitional pharmaceutical care program for patients discharged from the hospital.一项针对出院患者的过渡性药学服务项目的成本效益分析
PLoS One. 2017 Apr 26;12(4):e0174513. doi: 10.1371/journal.pone.0174513. eCollection 2017.
6
Cost-effectiveness of comprehensive medication reviews versus noncomprehensive medication review interventions and subsequent successful medication changes in a Medicare Part D population.医疗保险部分 D 人群中综合药物审查与非综合药物审查干预措施的成本效益,以及随后成功的药物改变。
J Manag Care Spec Pharm. 2015 May;21(5):381-9. doi: 10.18553/jmcp.2015.21.5.381.
7
The economics of medicines optimization: policy developments, remaining challenges and research priorities.药品优化的经济学:政策进展、尚存挑战及研究重点
Br Med Bull. 2014 Sep;111(1):45-61. doi: 10.1093/bmb/ldu021.